Op-eds
340B Drug Discount Program Should Be on GAO’s High-Risk List
RCH: Nothing has been done to reform 340B and stop hospitals and for-profit pharmacies from enriching themselves.
The F-35 may be unsalvageable
The Hill: The time has come reduce the cost and scope of the F-35 program.
Earmarks Are Corrupt, Costly, and Inequitable
Joint op-ed from Sen. Ernst and CAGW President Tom Schatz in NRO.
These five items should top Biden’s defense priorities
Defense News: The Biden administration has the opportunity to institute reforms in several crucial areas at the DoD.
Earmarks are inequitable, corrupt, and costly — they should not be brought back
The Hill: Earmarks contain many hidden costs.
Congress' penchant for unpunctuality
The Hill: Frequent use of CRs demonstrates remarkably poor governance from Congress.
Congress' Penchant for Unpunctuality
The Hill: Given their track record, senators and representatives will likely miss yet another deadline.
Student Borrowers, Not Taxpayers, Should Be on the Hook for Their Own Debt
Washington Examiner: Erasing student loans will do more harm to students and the economy in the long run.
Pre-Existing Conditions Will Be Covered by Whoever Wins the Election
Inside Sources: Republicans and President Trump, just like Democrats, believe people with pre-existing conditions should be protected.
End the Pentagon’s OCO slush fund
Defense News: The OCO has been greatly expanded and used for unrelated purposes.
Price Controls Have Never Worked, And They Won’t Work On Drug Prices
Daily Caller: Price controls distort markets, create shortages and exacerbate the problem they are intended to solve.
Don't tap COVID relief for IT modernization funds
FCW: Allocating $1 billion from the HEROES Act for the TMF is completely unrelated to the pandemic.
